Yasmeen Rahimi
Stock Analyst at Piper Sandler
(3.68)
# 829
Out of 4,732 analysts
77
Total ratings
37.33%
Success rate
11.88%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UPB Upstream Bio | Initiates: Overweight | $75 | $11.00 | +581.82% | 1 | Nov 5, 2024 | |
| NKTR Nektar Therapeutics | Initiates: Overweight | $7 | $0.89 | +684.75% | 1 | Nov 4, 2024 | |
| SAGE Sage Therapeutics | Reiterates: Overweight | $52 → $26 | $7.08 | +267.23% | 2 | Oct 30, 2024 | |
| EWTX Edgewise Therapeutics | Maintains: Overweight | $48 → $51 | $26.26 | +94.21% | 3 | Oct 11, 2024 | |
| NAMS NewAmsterdam Pharma Company | Reiterates: Overweight | $37 | $23.55 | +57.11% | 2 | Sep 23, 2024 | |
| ZURA Zura Bio | Maintains: Overweight | $26 | $1.77 | +1,368.93% | 2 | Sep 19, 2024 | |
| SLRN Acelyrin | Maintains: Overweight | $68 → $20 | $1.99 | +905.03% | 2 | Aug 14, 2024 | |
| IMUX Immunic | Reiterates: Overweight | $28 | $0.95 | +2,838.09% | 3 | Jul 16, 2024 | |
| CRNX Crinetics Pharmaceuticals | Maintains: Overweight | $97 | $37.35 | +159.71% | 4 | Jul 2, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Overweight | $270 | $70.54 | +282.76% | 3 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $76 | $40.90 | +85.82% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 | $6.86 | +264.43% | 3 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $30 | $10.30 | +191.26% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $6 → $12 | $5.06 | +137.15% | 2 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $36 | $51.89 | -30.62% | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $0.62 | +1,351.61% | 1 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $180 | $37.00 | +386.49% | 2 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 | $0.96 | +1,459.41% | 1 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $336 | $293.64 | +14.43% | 3 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $16 | $2.93 | +446.08% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $80 | $15.85 | +404.73% | 1 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $93 | $46.88 | +98.38% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $93 | $27.06 | +243.68% | 3 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $65 | $18.00 | +261.11% | 1 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $57 | $23.86 | +138.89% | 2 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $67 | $4.39 | +1,426.20% | 1 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $35 | $36.82 | -4.94% | 3 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $22 | $0.86 | +2,471.60% | 1 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $87 | $5.25 | +1,557.14% | 3 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $94 | $13.77 | +582.64% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $75 → $175 | $34.24 | +411.10% | 4 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $0.69 | +1,349.28% | 1 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $72 | $45.74 | +57.41% | 5 | Jun 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $63 → $27 | $11.21 | +140.86% | 1 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $54 → $19 | $6.31 | +201.11% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $50 | $2.02 | +2,375.25% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $40 | $1.40 | +2,757.14% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $18 | $0.74 | +2,332.43% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $0.56 | +3,663.44% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $16.79 | +358.61% | 1 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $77 | $46.95 | +64.00% | 1 | Jul 31, 2020 |
Upstream Bio
Nov 5, 2024
Initiates: Overweight
Price Target: $75
Current: $11.00
Upside: +581.82%
Nektar Therapeutics
Nov 4, 2024
Initiates: Overweight
Price Target: $7
Current: $0.89
Upside: +684.75%
Sage Therapeutics
Oct 30, 2024
Reiterates: Overweight
Price Target: $52 → $26
Current: $7.08
Upside: +267.23%
Edgewise Therapeutics
Oct 11, 2024
Maintains: Overweight
Price Target: $48 → $51
Current: $26.26
Upside: +94.21%
NewAmsterdam Pharma Company
Sep 23, 2024
Reiterates: Overweight
Price Target: $37
Current: $23.55
Upside: +57.11%
Zura Bio
Sep 19, 2024
Maintains: Overweight
Price Target: $26
Current: $1.77
Upside: +1,368.93%
Acelyrin
Aug 14, 2024
Maintains: Overweight
Price Target: $68 → $20
Current: $1.99
Upside: +905.03%
Immunic
Jul 16, 2024
Reiterates: Overweight
Price Target: $28
Current: $0.95
Upside: +2,838.09%
Crinetics Pharmaceuticals
Jul 2, 2024
Maintains: Overweight
Price Target: $97
Current: $37.35
Upside: +159.71%
Praxis Precision Medicines
Jul 1, 2024
Maintains: Overweight
Price Target: $270
Current: $70.54
Upside: +282.76%
Jun 26, 2024
Initiates: Overweight
Price Target: $76
Current: $40.90
Upside: +85.82%
Jun 21, 2024
Maintains: Overweight
Price Target: $25
Current: $6.86
Upside: +264.43%
Jun 13, 2024
Initiates: Overweight
Price Target: $30
Current: $10.30
Upside: +191.26%
May 7, 2024
Upgrades: Overweight
Price Target: $6 → $12
Current: $5.06
Upside: +137.15%
Apr 16, 2024
Maintains: Overweight
Price Target: $31 → $36
Current: $51.89
Upside: -30.62%
Apr 4, 2024
Initiates: Overweight
Price Target: $9
Current: $0.62
Upside: +1,351.61%
Mar 27, 2024
Maintains: Overweight
Price Target: $180
Current: $37.00
Upside: +386.49%
Mar 27, 2024
Maintains: Overweight
Price Target: $15
Current: $0.96
Upside: +1,459.41%
Mar 14, 2024
Reiterates: Overweight
Price Target: $336
Current: $293.64
Upside: +14.43%
Mar 4, 2024
Maintains: Overweight
Price Target: $7 → $16
Current: $2.93
Upside: +446.08%
Feb 16, 2024
Initiates: Overweight
Price Target: $80
Current: $15.85
Upside: +404.73%
Feb 5, 2024
Initiates: Overweight
Price Target: $93
Current: $46.88
Upside: +98.38%
Oct 27, 2023
Maintains: Overweight
Price Target: $58 → $93
Current: $27.06
Upside: +243.68%
Oct 25, 2023
Initiates: Overweight
Price Target: $65
Current: $18.00
Upside: +261.11%
Oct 24, 2023
Maintains: Overweight
Price Target: $28 → $57
Current: $23.86
Upside: +138.89%
Aug 8, 2023
Initiates: Overweight
Price Target: $67
Current: $4.39
Upside: +1,426.20%
Jul 3, 2023
Reiterates: Overweight
Price Target: $35
Current: $36.82
Upside: -4.94%
Mar 7, 2023
Initiates: Overweight
Price Target: $22
Current: $0.86
Upside: +2,471.60%
Feb 8, 2023
Maintains: Overweight
Price Target: $87
Current: $5.25
Upside: +1,557.14%
Jan 27, 2023
Initiates: Overweight
Price Target: $94
Current: $13.77
Upside: +582.64%
Jan 17, 2023
Maintains: Overweight
Price Target: $75 → $175
Current: $34.24
Upside: +411.10%
Aug 12, 2022
Initiates: Overweight
Price Target: $10
Current: $0.69
Upside: +1,349.28%
Jun 10, 2022
Maintains: Overweight
Price Target: $50 → $72
Current: $45.74
Upside: +57.41%
May 18, 2022
Maintains: Overweight
Price Target: $63 → $27
Current: $11.21
Upside: +140.86%
May 18, 2022
Maintains: Overweight
Price Target: $54 → $19
Current: $6.31
Upside: +201.11%
Nov 15, 2021
Initiates: Overweight
Price Target: $50
Current: $2.02
Upside: +2,375.25%
Aug 24, 2021
Initiates: Overweight
Price Target: $40
Current: $1.40
Upside: +2,757.14%
Jun 11, 2021
Initiates: Overweight
Price Target: $18
Current: $0.74
Upside: +2,332.43%
Aug 26, 2020
Initiates: Overweight
Price Target: $21
Current: $0.56
Upside: +3,663.44%
Aug 26, 2020
Initiates: Overweight
Price Target: $77
Current: $16.79
Upside: +358.61%
Jul 31, 2020
Initiates: Overweight
Price Target: $77
Current: $46.95
Upside: +64.00%